Avertix to Participate in the BTIG Digital Health Forum
November 06, 2023 08:30 ET
|
Avertix Medical Inc.
Avertix to Participate in the BTIG Digital Health Forum
Avertix Data Presented at TCT 2023 Shows 150% Increase in Medication Adjustments of Antiarrhythmics for High-Risk Heart Attack Survivors
October 24, 2023 08:30 ET
|
Avertix Medical Inc.
Patients with Guardian™ System alarms active experienced a substantial increase in new prescriptions or medication adjustments related to rate and rhythm abnormalities, with 29.0% of Alarms ON...
Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
October 04, 2023 07:30 ET
|
Avertix Medical Inc.
EATONTOWN, N.J. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), formerly known as Angel Medical Systems, Inc., a company focused on improving...
Avertix to Present at Two Upcoming Investor Conferences in September 2023
September 11, 2023 08:30 ET
|
Avertix Medical Inc.
EATONTOWN, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), a company focused on improving long-term management and outcomes of high-risk coronary disease...
Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring
August 16, 2023 08:30 ET
|
Avertix Medical Inc.
The Avertix Guardian™ System, the first and only FDA approved implantable heart attack warning system, now available at the Heart & Rhythm Institute of Trinity, extending their commitment to...
Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors
July 17, 2023 08:00 ET
|
Avertix Medical Inc.
Recently served as Boston Scientific Executive Vice President and Global Chief Medical Officer Professor Meredith brings to Avertix over 35 years of cardiology experience and commitment to advancing...
Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando
June 13, 2023 08:30 ET
|
Avertix Medical Inc.
EATONTOWN, N.J. and ORLANDO, Fla., June 13, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), formerly known as Angel Medical Systems, Inc., a company focused on improving...
Avertix to Participate in the Sidoti Summer Small Cap Conference
June 05, 2023 09:00 ET
|
Avertix Medical Inc.
EATONTOWN, N.J. and NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), a company focused on improving long-term management and outcomes of high-risk...
Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation
May 03, 2023 08:30 ET
|
Avertix Medical Inc.
- Transaction values Avertix at an enterprise value of $195 million- Avertix developed the Guardian™ System, the first and only FDA-approved solution designed to detect and warn patients of cardiac...
Angel Medical Systems, Creator of the Guardian™, First Implantable Cardiac Alert System, Changes Name to Avertix Medical Inc. and Welcomes New CEO and CFO to Drive Continued Growth and Success
April 27, 2023 08:30 ET
|
Avertix Medical Inc.
New company name chosen to represent focus on ‘averting’ serious cardiac complications with state-of-the-art Guardian™ monitoring and alerting system President and CEO Tim Moran and Chief Financial...